UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of neurology, ISSN 0364-5134, 06/2011, Volume 69, Issue 6, pp. 986 - 996
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Disability Evaluation | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Parkinson Disease - complications | Cross-Sectional Studies | Levodopa - therapeutic use | Humans | Middle Aged | Dopamine Agonists - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - etiology | Male | Parkinson Disease - drug therapy | Case-Control Studies | Antiparkinson Agents - therapeutic use | Neuropsychological Tests | Psychiatric Status Rating Scales | Analysis of Variance | Cognition Disorders - etiology | Female | Aged | Medical research | Impulsivity | Parkinsons disease | Index Medicus
Journal Article
Movement disorders, ISSN 0885-3185, 02/2015, Volume 30, Issue 2, pp. 121 - 127
impulse control disorder | dopamine agonists | Parkinson's disease | Dopamine agonists | Impulse control disorder | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Parkinson Disease - complications | Brain - physiopathology | Humans | Dopamine Agonists - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - etiology | Disruptive, Impulse Control, and Conduct Disorders - complications | Parkinson Disease - drug therapy | Brain - drug effects | Disruptive, Impulse Control, and Conduct Disorders - diagnosis | Animals | Compulsive Behavior - drug therapy | Compulsive Behavior - diagnosis | Dopamine - metabolism | Index Medicus
Journal Article
Current opinion in neurology, ISSN 1350-7540, 08/2011, Volume 24, Issue 4, pp. 324 - 330
impulse control disorders | impulsivity | Parkinson's disease | pathological gambling | dopamine agonists | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Dopamine - therapeutic use | Parkinson Disease - complications | Receptors, Dopamine - metabolism | Humans | Disruptive, Impulse Control, and Conduct Disorders - etiology | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Disruptive, Impulse Control, and Conduct Disorders - physiopathology | Disruptive, Impulse Control, and Conduct Disorders - epidemiology | Multicenter Studies as Topic | Parkinson Disease - epidemiology | Reward | Index Medicus | Impulse control disorders | Parkinson’s disease
Journal Article
4.
Full Text
Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
Neurology, ISSN 0028-3878, 08/2019, Volume 93, Issue 7, pp. e675 - e687
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Dopamine Agonists - pharmacology | Parkinson Disease - complications | REM Sleep Behavior Disorder - complications | Humans | Middle Aged | REM Sleep Behavior Disorder - epidemiology | Risk Factors | Impulsive Behavior - drug effects | Disruptive, Impulse Control, and Conduct Disorders - complications | Male | Case-Control Studies | REM Sleep Behavior Disorder - drug therapy | Aged, 80 and over | Adult | Female | Aged | Impulsive Behavior - physiology | Longitudinal Studies | Index Medicus | Abridged Index Medicus | 165
Journal Article
Movement disorders, ISSN 0885-3185, 02/2015, Volume 30, Issue 2, pp. 141 - 149
fMRI | basal ganglia | pramipexole | prefrontal cortex | l‐dopa | 6‐OHDA | dopamine agonists | imaging | PET | Basal ganglia | Imaging | 6-OHDA | Dopamine agonists | l-dopa | Prefrontal cortex | FMRI | Pramipexole | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Parkinson Disease - complications | Humans | Dopamine Agonists - therapeutic use | Impulsive Behavior - drug effects | Disruptive, Impulse Control, and Conduct Disorders - complications | Parkinson Disease - drug therapy | Parkinson Disease - genetics | Brain - drug effects | Disruptive, Impulse Control, and Conduct Disorders - diagnosis | Animals | Disruptive, Impulse Control, and Conduct Disorders - genetics | Brain - pathology | Impulsive Behavior - physiology | Disease Models, Animal | Neurosciences | Diagnostic imaging | Parkinson's disease | Dopa | Index Medicus | L-DOPA
Journal Article
Brain (London, England : 1878), ISSN 0006-8950, 01/2011, Volume 134, Issue 1, pp. 36 - 49
impulse control disorders | Parkinson's disease | dyskinesias | oscillations | subthalamic nucleus | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Brain Waves - physiology | Parkinson Disease - complications | Dyskinesia, Drug-Induced - physiopathology | Subthalamic Nucleus - physiopathology | Levodopa - therapeutic use | Humans | Middle Aged | Electrophysiology | Disruptive, Impulse Control, and Conduct Disorders - complications | Male | Electrodes, Implanted | Parkinson Disease - drug therapy | Parkinson Disease - physiopathology | Antiparkinson Agents - adverse effects | Antiparkinson Agents - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - physiopathology | Magnetic Resonance Imaging | Analysis of Variance | Levodopa - adverse effects | Deep Brain Stimulation | Adult | Female | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Seminars in neurology, ISSN 0271-8235, 04/2017, Volume 37, Issue 2, pp. 186 - 192
Review Article | impulse control disorder | Parkinson's disease | dopamine agonist | striatum | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Impulsive Behavior | Parkinson Disease - complications | Dopamine | Humans | Disruptive, Impulse Control, and Conduct Disorders - etiology | Parkinson Disease - psychology | Dopamine Agonists | Index Medicus | Parkinson’s disease
Journal Article
Brain (London, England : 1878), ISSN 0006-8950, 2011, Volume 134, Issue 5, pp. 1438 - 1446
gambling | Parkinson's; disease | risk | dopamine | decision making | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Medical sciences | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Parkinson Disease - complications | Humans | Middle Aged | Risk Factors | Dopamine Agonists - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - etiology | Magnetic Resonance Imaging - methods | Male | Parkinson Disease - drug therapy | Image Processing, Computer-Assisted - methods | Oxygen - blood | Analysis of Variance | Risk-Taking | Brain Mapping | Adult | Female | Aged | Index Medicus | Abridged Index Medicus | Original
Journal Article
9.
Full Text
Naltrexone for impulse control disorders in Parkinson disease: A placebo-controlled study
Neurology, ISSN 0028-3878, 08/2014, Volume 83, Issue 9, pp. 826 - 833
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases | Psychopathology. Psychiatry | Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy | Biological and medical sciences | Nervous system as a whole | Medical sciences | Nervous system (semeiology, syndromes) | Social behavior disorders. Criminal behavior. Delinquency | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Naltrexone - therapeutic use | Parkinson Disease - complications | Double-Blind Method | Narcotic Antagonists - therapeutic use | Humans | Middle Aged | Disruptive, Impulse Control, and Conduct Disorders - etiology | Female | Male | Aged | Index Medicus | Abridged Index Medicus | 165 | 321 | 135
Journal Article